This is the authors' abstract. We don't add key points for this paper.
It is well-known that profound physiological and biochemical changes occur throughout the course of pregnancy. At the same time, the role of pharmacogenomics in modulating the metabolism and response profile to numerous medications has been elucidated. Yet, the clinical impact of pharmacogenomics during pregnancy is less well understood. We present an overview of factors modulating the pharmacokinetics and pharmacodynamics of medications throughout the time span of pregnancy while providing insights on how pharmacogenomics may contribute to interindividual variability in drug metabolism and response amongst pregnant women.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Helldén et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: